Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.

Lee, Pei-Chang; Chao, Yee; Chen, Ming-Huang; Lan, Keng-Hsin; Lee, Chieh-Ju; Lee, I-Cheng; Chen, San-Chi; Hou, Ming-Chih; Huang, Yi-Hsiang

Lee, Pei-Chang; Chao, Yee; Chen, Ming-Huang; Lan, Keng-Hsin; Lee, Chieh-Ju; Lee, I-Cheng; Chen, San-Chi; Hou, Ming-Chih; Huang, Yi-Hsiang.

Affiliation

Lee PC; Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
Chao Y; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
Chen MH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Lan KH; Department of Oncology, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Lee CJ; Department of Oncology, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Lee IC; Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
Chen SC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Hou MC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
Huang YH; Institute of Clinical medicine, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.

Cancers (Basel) ; 12(1)2020 Jan 11.

Article in En | MEDLINE | ID: mdl-31940757

Key words

alpha fetoprotein response; immune checkpoint inhibitor; unresectable hepatocellular carcinoma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Taiwán Country of publication: Suiza

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google